Clinical Trials Logo

Clinical Trial Summary

The acceptability of vulvar vibration therapy has been evaluated in women with vulvodynia, and found to be acceptable, however has not been assessed in women with a primary complaint of vaginismus. This proposed study looks at the feasibility and acceptability of using clitoral vibration therapy, alongside current therapy, for women with vaginismus. It is likely that many, if not most, of these women will also have an element of vulvodynia. The investigators propose that the use of external clitoral or vulval vibration therapy is likely to be acceptable in most women with vaginismus, based on acceptability of vulvar vibration therapy in women with vulvodynia. It is proposed that vibrator therapy may help women with female sexual dysfunction to use vaginal dilators.


Clinical Trial Description

This is a nonrandomized controlled trial, with the initial cluster of patients receiving standard therapy, and the second cluster receiving standard therapy plus vibrator. Recruitment will be an initial 15 participants who will receive standard therapy, and then another 15 who will receive an external vibrator. This study will take place over approximately 12 months. Enrollment of patients will be from a joint psychosexual clinic led by a medical doctor and a clinical psychologist. Female patients are referred to this clinic by General Practitioners, from within the Sexual Health service, or via Gynaecologists, frequently with complaint of difficulty or pain with penetrative sex. Exclusion criteria will be: patients unable/ unwilling to consent, transgender male or on testosterone therapy, unable to understand written and/or verbal English, current dermtatological skin conditions requiring active treatment, genital herpes simplex virus within 3 months, or not reporting symptoms of vaginismus with no evidence of vaginismus on clinical examination. Trial information will be given at the initial appointment. If the patient wishes to enrol, than an initial baseline questionnaire will be given, and a follow up questionnaire will be filled out by phone contact at 3-4 months afterward the initial consultation at the patients consent. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04635345
Study type Interventional
Source Barts & The London NHS Trust
Contact Jessica Gaddie, MbCHb, BSc
Phone 0207 377 7315
Email j.gaddie1@nhs.net
Status Recruiting
Phase N/A
Start date August 11, 2021
Completion date August 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00638066 - Botulinum Toxin Injection for Treatment of Vaginismus Phase 3
Not yet recruiting NCT01530113 - Childhood Sexual Abuse, Vaginismus and Labor Dystocia N/A
Recruiting NCT05529407 - Trial of SVTampons vs Glass Vaginal Dilators in Treatment of Vaginismus N/A
Completed NCT01859507 - Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm N/A
Completed NCT04436172 - Spinal Anesthesia Facilitated Sexual Intercourse As A Treatment Option For Vaginismus N/A
Completed NCT00281372 - Sexual Dysfunction and Dental Care N/A
Completed NCT03176069 - Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus) N/A
Completed NCT01352546 - Botox Injection for Treatment of Vaginismus Phase 1
Recruiting NCT06397885 - Prospective On Market Patient-reported Outcomes for Milli
Completed NCT02430038 - Transperineal Ultrasound to Assess the Progress of Labour